Glatiramer acetate
1
Reactions 1325 - 30 Oct 2010 Glatiramer acetate Alopecia: case report A 42-year-old woman was diagnosed with relapsing- remitting multiple sclerosis in 1998 and initially received interferon β-1b. She began glatiramer acetate [dosage and route of administration not stated] therapy in 2004. In August 2006 she noticed substantial progressive hair loss over her scalp, pubic area, axillae and extremities. Her eyebrows and eyelashes were not affected. Non-scarring alopecia was diagnosed. Glatiramer acetate therapy was stopped for 3 months and the woman reported complete remission of her alopecia. The glatiramer acetate therapy was resumed for 6 months with no recurrence of alopecia. Pacheco MF, et al. Reversible alopecia associated with glatiramer acetate. Archives of Neurology 67: 1154, No. 9, Sep 2010 - USA 803042782 1 Reactions 30 Oct 2010 No. 1325 0114-9954/10/1325-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Transcript of Glatiramer acetate
Reactions 1325 - 30 Oct 2010
Glatiramer acetate
Alopecia: case reportA 42-year-old woman was diagnosed with relapsing-
remitting multiple sclerosis in 1998 and initially receivedinterferon β-1b. She began glatiramer acetate [dosage androute of administration not stated] therapy in 2004. InAugust 2006 she noticed substantial progressive hair lossover her scalp, pubic area, axillae and extremities. Hereyebrows and eyelashes were not affected. Non-scarringalopecia was diagnosed. Glatiramer acetate therapy wasstopped for 3 months and the woman reported completeremission of her alopecia. The glatiramer acetate therapywas resumed for 6 months with no recurrence of alopecia.Pacheco MF, et al. Reversible alopecia associated with glatiramer acetate. Archivesof Neurology 67: 1154, No. 9, Sep 2010 - USA 803042782
1
Reactions 30 Oct 2010 No. 13250114-9954/10/1325-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
